EPISODE · Nov 2, 2022 · 17 MIN
Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous
from PharmaTalkRadio · host Conference Forum
In this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities. To learn more about the PODD Conference, please visit PODDConference.com.
What this episode covers
In this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities. To learn more about the PODD Conference, please visit PODDConference.com.
NOW PLAYING
Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.